Tag

Weightloss

All articles tagged with #weightloss

health8 days ago•42 min saved

GLP-1 Weight-Loss Drugs May Trigger Scurvy if Diet Slips, Experts Warn

Reports of scurvy linked to GLP-1 weight‑loss drugs have risen as these medications curb appetite and food intake, potentially causing vitamin C and other nutrient deficiencies. Experts note that malnutrition risk increases when appetite suppression leads to reduced consumption, and advise nutritional status assessment, meal planning with a dietitian, and targeted supplementation (e.g., vitamin C 100–200 mg) to prevent scurvy and other deficiencies while continuing GLP-1 therapy. Scurvy is reversible with proper supplementation and dietary adjustments.

via Healthline|

#glp-1 #health #malnutrition

business11 days ago•2 min saved

Novo Nordisk stock slides after CagriSema misses non-inferiority vs Lilly’s tirzepatide

Novo Nordisk’s stock fell about 15% after its weight‑loss candidate CagriSema failed to demonstrate non‑inferiority to Eli Lilly’s tirzepatide over 84 weeks (23% weight loss on CagriSema vs 25.5% for tirzepatide at 84 weeks). Lilly’s drug remains dominant in the market, and Novo is pursuing higher‑dose trials while facing competition, U.S. price pressure, and looming loss of exclusivity for Wegovy and Ozempic. The stock traded at its lowest since June 2021, and Lilly stock rose in premarket trading as Novo cautioned about slower growth in 2026.

via CNBC|

#business #cagrisema #novonordisk

health14 days ago•6 min saved

Front-loading calories at breakfast linked to weight loss in small study

A small randomized crossover trial in adults with overweight/obesity found that eating 45% of daily calories at a large breakfast and 20% at dinner led to weight loss over 28 days, with two plan variants—high-protein (less hungry) and high-fiber (slightly more weight loss and greater gut microbiome diversity). The high-fiber group lost about 4.87 kg and the high-protein group about 3.87 kg; both improved blood pressure and lipids. Limitations include a small, mostly male sample and short duration, so longer, larger studies are needed, with personalization and consideration of circadian factors.

via Medical News Today|

#breakfast #fiber #health

health1 month ago•1 min saved

GLP-1 users regain weight after 18 months, study finds

A review of research indicates that individuals who stop using GLP-1 drugs like Ozempic and Wegovy for weight loss tend to regain their lost weight within approximately 18 months, and this regain occurs faster than with behavioral methods like dieting or exercise. To maintain health benefits after discontinuing these medications, lasting lifestyle changes are essential.

via The Boston Globe|

#glp-1 #health #ozempic

health1 month ago•2 min saved

Experts Warn About Risks of Weight-Loss Drugs and Injections This Year

Doctors warn that weight-loss drugs like Ozempic and Wegovy, originally for diabetes, carry risks such as side effects and potential weight regain after stopping, emphasizing the importance of lifestyle changes and caution against viewing these medications as quick fixes.

via WTOP|

#glp-1-drugs #health #ozempic

health-and-wellness2 months ago•1 min saved

Strategic Fasting: A Key to Losing Belly Fat

Strategic fasting, a mindful and structured eating pattern, may be an effective way to lose belly fat by improving how the body stores and uses energy, offering an alternative to simply exercising more or reducing calories.

via Daily Nation|

#bellyfat #energy-metabolism #fasting

health2 months ago•2 min saved

Risks of Discontinuing GLP-1s Revealed

Many users of GLP-1 drugs like Ozempic struggle to stop using them due to intense hunger and weight regain, suggesting a potential lifelong dependency. While some, like Ellen Ogley, maintain weight loss through lifestyle changes, others experience significant weight regain, highlighting the importance of healthy habits during treatment. Experts recommend developing an exit strategy that includes lifestyle modifications to sustain weight loss after discontinuing the medication.

via Yahoo News New Zealand|

#dependency #glp-1 #health

healthcare2 months ago•22 min saved

Eli Lilly's Oral GLP-1 Therapy Sustains Weight Loss Post-Injection

Eli Lilly's oral GLP-1 receptor agonist, orforglipron, successfully maintained weight loss in a Phase 3 trial after patients switched from injectable therapies, leading Lilly to submit it for FDA approval as a treatment for obesity.

via Eli Lilly|

#healthcare #lilly #obesity

health-and-medicine2 months ago•4 min saved

Eli Lilly's New Weight-Loss Drugs Show Promising Results in Phase 3 Trials

Eli Lilly's new obesity pill helps patients maintain weight loss after switching from injections like Wegovy and Zepbound, with promising trial results suggesting it could serve as a needle-free long-term treatment option, potentially capturing significant market share in the growing weight loss drug industry.

via CNBC|

#elililly #health-and-medicine #obesity

health3 months ago•3 min saved

WHO Launches Global Guidelines for GLP-1 Weight Loss Drugs Amid Shortages

The WHO highlights the potential of weight loss drugs like Mounjaro as a significant breakthrough in treating obesity, emphasizing the need for increased access, affordability, and comprehensive support, while noting these medications are not a standalone solution and should be part of broader lifestyle changes.

via The Guardian|

#glp-1 #health #medications

health6 months ago•4 min saved

Green Tea Microbeads Offer New Hope for Weight Loss

Researchers in China have developed fat-blocking microbeads made from green tea, vitamin E, and seaweed that showed promising results in rats fed a high-fat diet, suggesting a potential noninvasive dietary strategy for weight loss. Human trials are underway to confirm safety and effectiveness, and the microbeads could serve as an alternative to drugs and surgery for obesity management.

via AOL.com|

#dietary #green-tea #health

health6 months ago•1 min saved

Understanding Post-Weight Loss Changes and Ozempic Effects

The article discusses the issue of loose, sagging skin that often results from rapid weight loss due to obesity drugs like tirzepatide and others, highlighting that while these medications improve health, they can leave individuals self-conscious about excess skin, which is difficult to address with creams or treatments.

via The New York Times|

#bariatrics #bodycontouring #health

health6 months ago•4 min saved

New Dual-Action Weight Loss and Diabetes Drug Outperforms Current Treatments

A new drug called ecnoglutide shows promise as a treatment for type 2 diabetes and weight loss, potentially rivaling Ozempic, with clinical trials indicating it may be more effective in lowering blood sugar and promoting weight loss than dulaglutide, and similar or better than semaglutide, though it is not yet approved for market.

via Newsweek|

#clinicaltrials #diabetes #ecnoglutide

health6 months ago•9 min saved

Lilly's Orforglipron Shows Promise in Obesity Treatment Despite Investor Concerns

Eli Lilly's obesity pill, orforglipron, despite underwhelming trial data compared to Novo Nordisk's oral semaglutide, remains a competitive option due to its potential advantages in manufacturing, cost, and ease of use, with market predictions favoring Lilly's larger global rollout and market share in the future.

via CNBC|

#clinicaltrials #elililly #health

health6 months ago•1 min saved

The Impact of GLP-1s on Weight Loss and Relationships

The article discusses how the mainstream adoption of GLP-1 drugs for weight loss has led to social tensions, exemplified by Marcia Berry's experience of being ghosted by her hairstylist after using a non-branded GLP-1 drug to lose weight, highlighting issues of jealousy and judgment surrounding these medications.

via The Boston Globe|

#diabetes #glp-1 #health